These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6245565)

  • 61. [Congenital nephrogenic diabetes insipidus: a difficult diagnosis?].
    van Lieburg AF; Knoers NV; Monnens LA
    Ned Tijdschr Geneeskd; 1997 Mar; 141(13):609-12. PubMed ID: 9190534
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Plasma values of arginine vasopressin in patients treated with lithium carbonate].
    Lucas A; Sanmartí A; Catalán R; Galard R; Castellanos JM; Martínez-Pina A; Foz M
    Med Clin (Barc); 1984 Sep; 83(7):276-9. PubMed ID: 6436592
    [No Abstract]   [Full Text] [Related]  

  • 63. 1-deamino-/4-valine-8-D-arginine/-vasopressin (dVDAVP), a new synthetic vasopressin analog for treating diabetes insipidus.
    László FA; Czakó L
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):39-43. PubMed ID: 7056603
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [A new synthetic analog of vasopressin, desamino-6 carba-(8-D-arginin)-vasopressin, active against diabetes insipidus refractory to vasopressin and adiuretin spofa (author's transl)].
    Schück O; Cort JH; Stríbrná J; Skopková J; Jost K
    Cas Lek Cesk; 1975 Feb; 114(6):172-5. PubMed ID: 1092463
    [No Abstract]   [Full Text] [Related]  

  • 65. Pharmacokinetics of 1-desamino-8-D-arginine vasopressin (DDAVP) in patients with central diabetes insipidus.
    Pullan PT; Burger HG; Johnston CI
    Clin Endocrinol (Oxf); 1978 Sep; 9(3):273-8. PubMed ID: 709897
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The role of urinary prostaglandin E and cyclic AMP in the polyuria of hypokalemia in rats.
    Gullner HG; Bartter FC
    Prostaglandins Med; 1980 Jan; 4(1):13-9. PubMed ID: 6247732
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Preliminary study of the role of arginine vasopressin in arterial hypertension].
    Volpe M; Ferrara N; Ungaro B; Chiariello M; Rengo F; Ricciardelli B; Condorelli M
    Boll Soc Ital Cardiol; 1979; 24(11):1235-8. PubMed ID: 400397
    [No Abstract]   [Full Text] [Related]  

  • 68. Hereditary central diabetes insipidus: plasma levels of antidiuretic hormone in a family with a possible osmoreceptor defect.
    Toth EL; Bowen PA; Crockford PM
    Can Med Assoc J; 1984 Nov; 131(10):1237-41. PubMed ID: 6498676
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Use of desmopressin (DDAVP) in the detection of decreased fibrinolytic capacity in persons with idiopathic venous thrombosis and myocardial infarct at a young age].
    Cepelák V; Dvorák J
    Vnitr Lek; 1985 Mar; 31(3):232-9. PubMed ID: 4036009
    [No Abstract]   [Full Text] [Related]  

  • 70. The kinins and prostaglandins in hypertension.
    Abe K
    Clin Endocrinol Metab; 1981 Nov; 10(3):577-605. PubMed ID: 6284417
    [No Abstract]   [Full Text] [Related]  

  • 71. Differential diagnosis of diabetes insipidus: use of DDAVP to terminate the seven-hour water deprivation test.
    Hendricks SA; Lippe B; Kaplan SA; Lee WN
    J Pediatr; 1981 Feb; 98(2):244-6. PubMed ID: 7463222
    [No Abstract]   [Full Text] [Related]  

  • 72. Diabetes insipidus.
    Saborio P; Tipton GA; Chan JC
    Pediatr Rev; 2000 Apr; 21(4):122-9; quiz 129. PubMed ID: 10756175
    [No Abstract]   [Full Text] [Related]  

  • 73. Renal prostaglandins: relationship to the development of blood pressure and concentrating capacity in pre-term and full term healthy infants.
    Joppich R; Scherer B; Weber PC
    Eur J Pediatr; 1979; 132(4):253-9. PubMed ID: 230048
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Changes in tissue sensitivity to vasopressin in hereditary hypothalamic diabetes insipidus.
    Block LH; Furrer J; Locher RA; Siegenthaler W; Vetter W
    Klin Wochenschr; 1981 Aug; 59(15):831-6. PubMed ID: 6267361
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dependence of plasma renin activity on protaglandin excretion in essential hypertension.
    Ylitalo P; Vapaatalo H; Metsä-Ketelä T; Pitkäjärvi T
    Acta Physiol Scand; 1978 Jan; 102(1):120-2. PubMed ID: 626085
    [No Abstract]   [Full Text] [Related]  

  • 76. Nephrogenic diabetes insipidus: clinical and pathophysiological aspects.
    Niaudet P; Dechaux M; Trivin C; Loirat C; Broyer M
    Adv Nephrol Necker Hosp; 1984; 13():247-60. PubMed ID: 6089520
    [No Abstract]   [Full Text] [Related]  

  • 77. Diabetes insipidus with renal resistance to vasopressin in the desoxycorticosterone-treated dog: a possible role for prostaglandins.
    Gullner HG; West D; Gill JR; Robertson GL
    Ren Physiol; 1987; 10(1):40-6. PubMed ID: 3479817
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Maintenance of unstable kidney donors.
    Pelosi G; Zanghi F; Agnes S; Magalini SC
    Eur J Anaesthesiol; 1986 May; 3(3):209-17. PubMed ID: 3536493
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of vasopressin, water load and aminophylline on adenosine 3', 5'-phosphate in human urine.
    Takahashi K
    Kobe J Med Sci; 1971 Mar; 17(1):17-33. PubMed ID: 4334309
    [No Abstract]   [Full Text] [Related]  

  • 80. [Vasopressin-sensitive diabetes insipidus. Case histories].
    Marelli A; Cappellini A; Madini G; Bisceglie G; Boldori L
    Minerva Med; 1992 Apr; 83(4):207-11. PubMed ID: 1574192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.